Kobe University, also known in the Kansai region as Shindai, is a leading Japanese national university located in the city of Kobe, in Hyōgo.

During the past decade, Kobe University conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kobe University" are "Angina Pectoris" (1 trials), "Coronary Artery Disease" (1 trials), "Coronary Artery Occlusion" (1 trials), "Ischemic Heart Disease" (1 trials) and "Myocardial Ischemia" (1 trials). Many other conditions were trialed in "Kobe University" in a lesser frequency.

Most popular intervention types in "Kobe University" are "Drug" (3 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "ABSORB GT1 BVS" (1 trials), "Antecolic gastro- or duodeno- jejunostomy in the pancreaticoduodenectomy" (1 trials), "CP-690,550" (1 trials), "Conventional procedure" (1 trials) and "FIRINOX" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kobe University" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Kobe University". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Kobe University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kobe University, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".